ElendiLabs Logo
Back to Articles

Local Regulatory Experts

Connect with regulatory affairs consultancies specializing in this region.

Qualtech Consulting Corporation

Taiwan, China, Japan, Singapore, Hong Kong, Malaysia, Philippines, Vietnam, Australia, Germany, Korea, Thailand, USA

Registration

A specialized medical device consulting firm offering a one-stop solution for complex global regulatory challenges. We offer real-time regulatory and clinical support, local representation, and QMS services across 13 markets, ensuring efficient market entry and compliance.

Cobridge Co., Ltd.

Tokyo, Japan

Registration

We assist medical device companies with the medical device registration and approval in Japan. Regulatory consulting services and DMAH services for foreign manufacturers to enter Japanese market.

MDREX, Medical Device, Digital Health Consulting Group

Seoul, Republic of Korea (HQ), Japan Office

Registration
Distribution
Marketing

We offer total solutions for market entry in South Korea and global expansion (e.g., Japan, USA, Europe). Key areas include product approval, reimbursement listings (HIRA), and Quality System certification (KGMP). They are particularly strong in innovative products like SaMD, medical wearables, and 3D printing for medical use, and provide in-depth expertise in cybersecurity and clinical trial planning.

CMIC Holdings Co., Ltd.

Tokyo, Japan (HQ), Osaka, Japan, Beijing, China, Seoul, South Korea, Taipei, Taiwan, Singapore, New York, USA, London, UK, Frankfurt, Germany, Sydney, Australia

Registration
Marketing

We operate globally, specializing in accelerating the development, manufacturing, and commercialization of drugs and medical devices. Their expertise spans Phase I to IV clinical trials, regulatory affairs, quality assurance, and manufacturing, with a strong focus on the Japanese and Asian markets. Key services include clinical operations (CRO), manufacturing (CDMO/CMO), site management (SMO), and comprehensive health analysis and solutions.

View More Consultancies in This Region
Other

December 25, 2025

Approximately 5 minutes

Points to Consider for the Preparation of Applications for Marketing Approval of Remanufactured Single-use Medical Devices in Japan

Points to Consider for the Preparation of Applications for Marketing Approval of Remanufactured Single-use Medical Devices in Japan

Overview

Japan’s Ministry of Health, Labour and Welfare (MHLW) issued the “Points to Consider for the Preparation of Applications for Marketing Approval of Remanufactured Single-use Medical Devices” to provide detailed instructions for applicants on how to prepare marketing approval applications for remanufactured single-use medical devices (R-SUDs). This guidance forms part of the regulatory framework under the Pharmaceuticals and Medical Devices Act (PMD Act) and related Enforcement Regulations. :contentReference[oaicite:0]{index=0}

Key Application Content Requirements

Scope & Definitions

  • The guidance applies to products recognized as remanufactured single-use medical devices (R-SUDs) under the Enforcement Regulations.
  • Definitions include the remanufacturing process, component recycling process, and final production process which span from receipt of used devices to release of the remanufactured product. :contentReference[oaicite:1]{index=1}

Application Structure

Applicants must complete all required fields of the marketing approval form, including:

  1. Category – Should match the category of the original single-use medical device (SUD).
  2. Name – Generic name must begin with “reprocessed”. Brand name must include “reprocessed” and the marketing authorization holder’s name.
  3. Intended Use/Indications – Must not exceed those of the original device.
  4. Shape, Structure, and Principle – Detailed information on recyclable and replacement components is required.
  5. Raw Materials – Describe materials of recyclable and replacement components, including maximum number of reprocessing cycles.
  6. Performance and Safety Specifications – Detailed performance and safety data comparable to the original device. :contentReference[oaicite:2]{index=2}

Manufacturing & Traceability

  • Include detailed reprocessing flow charts and description of each step: receipt, disassembly, cleaning, sterilization, and storage.
  • Explain traceability methods that link recycled parts to finished products throughout the process. :contentReference[oaicite:3]{index=3}

Use & Shelf Life

  • Intended use methods must mirror those of the original device.
  • Shelf life must be supported by stability data and specify differences by number of reprocessing cycles if applicable. :contentReference[oaicite:4]{index=4}

Q&A

Q: What must be shown about the intended use of an R-SUD?
A: The intended use or indications of the remanufactured device must not exceed those of the original single-use device. :contentReference[oaicite:5]{index=5}

Q: Must traceability be included in the application?
A: Yes. Applicants must describe methods to ensure traceability from collection of used parts to distribution of remanufactured products. :contentReference[oaicite:6]{index=6}

Q: Are replacement components treated differently?
A: Yes. Replacement components must be described with specifications and their own reprocessing cycle information. :contentReference[oaicite:7]{index=7}

Conclusion

This guidance ensures that applications for R-SUDs are complete, scientifically justified, and demonstrate that remanufactured products meet standards equivalent to original devices. :contentReference[oaicite:8]{index=8}

Need Expert Guidance?

Contact us at contact@elendilabs.com / +852 4416 5550